FdaApplication
NDA 204417
Identifiers
- fda_app_no: NDA204417
Properties
| Property | Value |
|---|---|
| applicant_name | TRIPOINT THERAPEUTICS |
| application_type | NDA |
| approval_date | 2018-12-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ELEPSIA XR | LEVETIRACETAM | 1GM | TABLET, EXTENDED RELEASE;ORAL |
| ELEPSIA XR | LEVETIRACETAM | 1.5GM | TABLET, EXTENDED RELEASE;ORAL |
2 products